mTOR-dependent signaling is active in 25–45% of hepatocellular carcinoma (HCC).[34] Activation correlates with shorter overall survival; mTOR activation is an independent predictor of recurrence after surgery.[35] mTOR regulates production of angiogenic factors. This evidence concerns the gene MTOR and hepatocellular carcinoma.